Litigation Details for IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD. (D.N.J. 2019)

IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD. (D.N.J. 2019)

Docket		Date Filed	2019-04-30
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Claire Claudia Cecchi
Jury Demand	Plaintiff	Referred To	Mark Falk
Patents	6,235,883; 7,915,225
Link to Docket	External link to docket

Details for IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD. (D.N.J. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2019-04-30	1	Complaint	“Roche Patents”); and • U.S. Patents Nos. 7,915,225 (“the ’225 Patent”), 8,119,605…United States Patent Nos. 8,063,182 (“the ’182 Patent”), 8,163,522 (“the ’522 Patent”), 7,915,225 (“the ’225…arthritis. The ’225 Patent, the ’605 Patent, and the ’631 Patent (“the Immunex Patents”), owned by Immunex…States Patent Nos. 8,063,182 (“the ’182 Patent”) and 8,163,522 (“the ’522 Patent”) (collectively… Patent”), and 8,722,631 (“the ’631 Patent”) (collectively, “the Immunex Patents”).	External link to document
2019-12-23	107	Amended Complaint	control element Such as, for U.S. Pat. No. 6,235,883 B1. Human antibodies can also be … 18 those described in U.S. Pat. No. 6,235,883 B1, incorporated encoding the human… U.S. Patent No. 8,063,182 (“the ’182 Patent”), • U.S. Patent No. 8,163,…Roche Patents”), • U.S. Patent No. 6,872,549 (“the ’549 Patent”), … U.S. Patent No. 6,924,124 (“the ’124 Patent”), • U.S. Patent No. 7,157,	External link to document